Sheller’s New Book Available, Read the First Chapter
NOW AVAILABLE ONLINE AND BY REQUEST AT YOUR LOCAL BOOKSTORE — Click here to buy the book online — PHARMAGEDDON: A Nation Betrayed A National Trial Lawyer Reveals an Industry Spinning Out of Control by Stephen A. Sheller, Esq. with New York Times best-selling author Sidney D. Kirkpatrick […]
$7.3M Astellas Pharma Off-Label Marketing and FCA Settlement
Digital Journal 2014-04-16 The whistleblower attorney team of Sheller P.C. announced today that Astellas Pharma U.S., Inc. has agreed to pay $7.3 million to resolve allegations by the Sheller whistleblower client that Astellas violated the False Claims Act by submitting fraudulent claims to government healthcare programs while marketing off-label the antifungal drug Mycamine for use in children. Court […]
Number One in Pennsylvania for Verdicts and Settlements 2014
2014-12-19 The $2.2 Billion settlement with Johnson & Johnson Leads the Pack The Legal Intelligencer reported that the largest verdict and settlement award in Pennsylvania between August 2013 and August 2014 was handled by Sheller, P.C. with a $2.2 billion settlement over healthcare giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals. J&J paid the […]
$1.4 Billion Whistleblower Settlement
2009-01-15 Sheller, P.C.’s whistleblower/qui tam clients help U.S. government recover $1.4 billion record settlement and criminal fine in Eli Lilly & Company Zyprexa marketing case. [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/ShellerPC_ZyprexaNewsRelease_200901152.pdf”]
